Traws Pharma (TRAW) Non-Current Assets (2012 - 2026)
Traws Pharma (TRAW) posted quarterly Non-Current Assets of $2.5 million for Q1 2026, up 1103.38% year-over-year from $207000.0 in Q1 2025, and down 5.57% quarter-over-quarter from $2.6 million in Q4 2025.
Traws Pharma (TRAW) Non-Current Assets (2012 - 2026) Analysis & Trends
Traws Pharma (TRAW) has reported Non-Current Assets for 15 consecutive years, with $2.5 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Non-Current Assets rose 1103.38% year-over-year to $2.5 million; the TTM figure through Mar 2026 stood at $8.2 million (up 3232.93% YoY), while the FY2025 annual figure was $2.6 million, up 23881.82% from the prior year.
- Non-Current Assets eased to $2.5 million in Q1 2026 per TRAW's latest filing, from $2.6 million in the prior quarter.
- Across five years, Non-Current Assets topped out at $2.8 million in Q3 2025 and bottomed at $11000.0 in Q4 2024.
- Historically, Non-Current Assets has averaged $511411.8 across 5 years, with a median of $27000.0 in 2023.
- Annual changes were most pronounced in 2022 — Non-Current Assets slumped 77.84% — and 2025, when it surged 23881.82%.
- Traws Pharma's Non-Current Assets stood at $25000.0 in 2022, then slipped by 8.0% to $23000.0 in 2023, then plunged by 52.17% to $11000.0 in 2024, then soared by 23881.82% to $2.6 million in 2025, then decreased by 5.57% to $2.5 million in 2026.
- Business Quant data shows TRAW's Non-Current Assets at $2.5 million in Q1 2026, $2.6 million in Q4 2025, and $2.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.66 Bn | 131.81 Bn | 2.84 Bn | 14.88 Bn |
| 2 | Regeneron Pharmaceuticals | 86.52 Bn | 78.52 Bn | 3.93 Bn | 23.28 Bn |
| 3 | Argenx Se | 65.30 Bn | 60.11 Bn | 1.37 Bn | 1.96 Bn |
| 4 | Moderna | 59.18 Bn | 54.04 Bn | 52.00 Mn | 5.15 Bn |
| 5 | BeOne Medicines | 42.08 Bn | 36.98 Bn | 1.53 Bn | 1.96 Bn |
| 6 | Alnylam Pharmaceuticals | 31.77 Bn | 28.46 Bn | 992.69 Mn | 938.60 Mn |
| 7 | BioNTech SE | 28.13 Bn | 9.74 Bn | 668.28 Mn | 6.80 Bn |
| 8 | Insmed | 27.51 Bn | 26.35 Bn | 358.27 Mn | 468.65 Mn |
| 9 | Royalty Pharma | 27.16 Bn | 26.32 Bn | - | 18.06 Bn |
| 10 | Traws Pharma | 5.54 Mn | 519,253.28 | - | 2.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.49 Mn |
| Dec 31, 2025 | 2.64 Mn |
| Sep 30, 2025 | 2.82 Mn |
| Jun 30, 2025 | 252,000.00 |
| Mar 31, 2025 | 207,000.00 |
| Dec 31, 2024 | 11,000.00 |
| Sep 30, 2024 | 13,000.00 |
| Jun 30, 2024 | 15,000.00 |
| Mar 31, 2024 | 19,000.00 |
| Dec 31, 2023 | 23,000.00 |
| Sep 30, 2023 | 27,000.00 |
| Jun 30, 2023 | 18,000.00 |
| Mar 31, 2023 | 22,000.00 |
| Dec 31, 2022 | 25,000.00 |
| Sep 30, 2022 | 29,000.00 |
| Jun 30, 2022 | 41,000.00 |
| Mar 31, 2022 | 45,000.00 |
| Dec 31, 2021 | 48,000.00 |
| Sep 30, 2021 | 54,000.00 |
| Jun 30, 2021 | 185,000.00 |